GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BNC Korea Co Ltd (XKRX:256840) » Definitions » EPS (Diluted)

BNC Korea Co (XKRX:256840) EPS (Diluted) : ₩314.00 (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BNC Korea Co EPS (Diluted)?

BNC Korea Co's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was ₩5.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩314.00.

BNC Korea Co's EPS (Basic) for the three months ended in Jun. 2024 was ₩5.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩323.00.

BNC Korea Co's EPS without NRI for the three months ended in Jun. 2024 was ₩5.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was ₩304.54.

During the past 3 years, the average EPS without NRIGrowth Rate was 105.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, BNC Korea Co's highest 3-Year average EPS without NRI Growth Rate was 105.20% per year. The lowest was -134.60% per year. And the median was 30.00% per year.


BNC Korea Co EPS (Diluted) Historical Data

The historical data trend for BNC Korea Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNC Korea Co EPS (Diluted) Chart

BNC Korea Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -134.87 27.54 -3,349.89 -813.00 334.00

BNC Korea Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.00 121.00 151.00 37.00 5.00

Competitive Comparison of BNC Korea Co's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, BNC Korea Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BNC Korea Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BNC Korea Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where BNC Korea Co's PE Ratio falls into.



BNC Korea Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

BNC Korea Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(25686.082-0)/76.904
=334.00

BNC Korea Co's Diluted EPS for the quarter that ended in Jun. 2024 is calculated as

Diluted EPS (Q: Jun. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(296.22-0)/59.244
=5.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩314.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BNC Korea Co  (XKRX:256840) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BNC Korea Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of BNC Korea Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


BNC Korea Co Business Description

Traded in Other Exchanges
N/A
Address
62 Seongseogongdan-ro 11-gil, Dalseo-gu, No 405, Structure 1, Daegu Techno Park Venture Factory, Daegu, KOR, 42713
BNC Korea Co Ltd is a Korean healthcare company. The company is engaged in manufacturing medicinal chemicals, antibiotics, and biological products. IIts product offering includes cutegel, cutegel lidocaine, FLORE lidocaine, ChungA-an, cutegel-M under the HA filler product line. While it also offers Skin booster filler, hibarry, gentaQ, and I.st products.

BNC Korea Co Headlines

No Headlines